Just published @TheLancet is the Oxford Phase 1 #SARSCoV2 vaccine trial with very encouraging safety data, neutralizing antibody and spike protein specific T cell response
https://www.thelancet.com/lancet/article/s0140-6736(20)31604-4
Just published @TheLancet is the Oxford Phase 1 #SARSCoV2 vaccine trial with very encouraging safety data, neutralizing antibody and spike protein specific T cell response https://www.thelancet.com/lancet/article/s0140-6736(20)31604-4
Just published @TheLancet is the Oxford Phase 1 #SARSCoV2 vaccine trial with very encouraging safety data, neutralizing antibody and spike protein specific T cell response https://www.thelancet.com/lancet/article/s0140-6736(20)31604-4
Just published @TheLancet is the Oxford Phase 1 #SARSCoV2 vaccine trial with very encouraging safety data, neutralizing antibody and spike protein specific T cell response https://www.thelancet.com/lancet/article/s0140-6736(20)31604-4
Just published @TheLancet is the Oxford Phase 1 #SARSCoV2 vaccine trial with very encouraging safety data, neutralizing antibody and spike protein specific T cell response https://www.thelancet.com/lancet/article/s0140-6736(20)31604-4
And another adenovirus vector vaccine Phase 2 trial (CanSIno) in China, published @TheLancet today, also found neutralizing antibodies in most people after a single dose with a good safety profile https://www.thelancet.com/lancet/article/s0140-6736(20)31605-6
And another adenovirus vector vaccine Phase 2 trial (CanSIno) in China, published @TheLancet today, also found neutralizing antibodies in most people after a single dose with a good safety profile https://www.thelancet.com/lancet/article/s0140-6736(20)31605-6
And another adenovirus vector vaccine Phase 2 trial (CanSIno) in China, published @TheLancet today, also found neutralizing antibodies in most people after a single dose with a good safety profile https://www.thelancet.com/lancet/article/s0140-6736(20)31605-6
And another adenovirus vector vaccine Phase 2 trial (CanSIno) in China, published @TheLancet today, also found neutralizing antibodies in most people after a single dose with a good safety profile https://www.thelancet.com/lancet/article/s0140-6736(20)31605-6
And another adenovirus vector vaccine Phase 2 trial (CanSIno) in China, published @TheLancet today, also found neutralizing antibodies in most people after a single dose with a good safety profile https://www.thelancet.com/lancet/article/s0140-6736(20)31605-6
You can follow @EricTopol.
Tip: mention @twtextapp on a Twitter thread with the keyword “unroll” to get a link to it.

Latest Threads Unrolled:
There are a lot of misconceptions about the Turkish diaspora in Germany. Since i just finished writing an essay about this topic I thought it's time to give other people
Read more
Las mejores calculadoras online en 2020A thread http://totumat.com/2020/11/26/las-mejores-calculadoras-online-en-2020/ Cuando se estudian asignaturas que requieren de cálculos complicados, nada mejor que contar con una buena calculadora.
Read more
Mitigating #ClimateChange is as much about taking up new techs as about leaving others behindMost studies focus on #coal's global downfall but another #energy tech decline is loomingRead my new
Read more